| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2587 | |||||||||||||||||||||||
| Submitter : | Mr. David Farinholt | Date & Time: | 12/05/2006 10:12:24 | |||||||||||||||||||||
| Organization : | Mr. David Farinholt | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| Dear Sirs,
I strongly oppose the aborted fetal cell line products discussed in the: "Open to Public Comment Docket Number 2006D-0383". I ask you to reject all attempts made upon all unborn human life after the moment of conception. Thank you. Dave Farinholt | ||||||||||||||||||||||||